Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients

Melanoma Research

Volumn 14, Issue 5, 2004, Pages 361-365

  Enk, Claes D ^a,b   Lotem, Michal ^a   Gimon, Zvi ^b   Hochberg, Malka ^a  

^a Department of Dermatology ^*  (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Lymph nodes; Melanoma marker heterogeneity; Micrometastases; Peripheral blood; Reverse transcriptase polymerase chain reaction

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MELANOMA; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TUMOR LOCALIZATION;

ADULT; AGED; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 7244248962     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200410000-00005     Document Type: Article

References (17)

1. Anichini A, Fossati G, Parmiani G. Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones. J Exp Med 1986; 163:215-220.
2. Runger TM, Klein CE, Becker JC, Brocker EB. The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr Opin Oncol 1994; 6:188-196.
3. Albino AP, Fountain JW. Molecular genetics of human malignant melanoma. Cancer Treat Res 1993; 65:201-255.
4. Jager E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jager D, et al. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 1997; 71:142-147.
5. Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, et al. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 1995; 25:340-347.
6. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, et al. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res 1989; 49:5091-5096.
7. Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, et al. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997; 57:1371-1376.
8. Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725-729.
9. Hearing VJ, Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989; 2:75-85.
10. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-1229.
11. Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A, et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994; 54:5695-5701.
12. Coulie PG, Brichard V, Van Pel A, Wolfel T, Schneider J, Traversari C, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180:35-42.
13. Bonin S, Niccolini B, Calacione R, Gambardella B, Geatti O, Stanta G, et al. Molecular analyses of sentinel lymph nodes: an open question. J Eur Acad Dermatol Venereol 2002; 16:34-39.
14. Dalerba P, Ricci A, Russo V, Rigatti D, Nicotra MR, Mottolese M, et al. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies. Int J Cancer 1998; 77:200-204.
15. Lotze MT, Rees RC. Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells. Cancer Immunol Immunother 2004; 53:256-261.
16. de Vries TJ, Fourkour A, Punt CJ, van de Locht LT, Wobbes T, van den Bosch S, et al. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br J Cancer 1999; 80:883-891.
17. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995; 13:2109-2116.